SCHEMBL14329624

SCHEMBL14329624

c1ccc2c(c1)c1ccccc1n2-c1ccc(-n2c3ccncc3c3c4ccc5cc6c(c7ccc(cc32)c4c57)c2cnccc2n6-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAOA P21397 4/20 0.40
▸ MAOB P27338 4/20 0.40
▸ ACHE P22303 2/20 0.40
▸ CYP2D6 P10635 1/20 0.36
▸ DDB1 Q16531 1/20 0.35
▸ CRBN Q96SW2 1/20 0.35
▸ CDK4 P11802 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAD52 P43351 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ METAP2 P50579 2/20 0.33
▸ CDK6 Q00534 1/20 0.33
▸ REN P00797 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14330540 0.95 MAOA (0.40) TOP2AKDM4EATML3MBTL1MAOA
SCHEMBL14329639 0.88 TOP2A (0.40) TOP2AKDM4EMAOAMAOBACHE
SCHEMBL14329649 0.88 MAPK10 (0.42) TOP2APOLB
SCHEMBL14329632 0.86 TOP2A (0.33) TOP2AKDM4EATML3MBTL1CDK4
SCHEMBL14330576 0.86 MAOA (0.39) TOP2AKDM4EATML3MBTL1MAOA
SCHEMBL14330536 0.85 KDM4E (0.35) TOP2AKDM4EATML3MBTL1MAOA
SCHEMBL14330546 0.84 KDM4E (0.37) TOP2AKDM4EATML3MBTL1MAOA
SCHEMBL14329611 0.84 MAPK10 (0.39) TOP2AATM
SCHEMBL14330617 0.84 REN (0.36) TOP2AKDM4EATML3MBTL1CDK4
SCHEMBL15865944 0.83 KIF11 (0.42) CDK4METAP2CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771844-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-07-08 — — US disclosed
US-8771844-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-07-08 — — US disclosed
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND DDT, DRD1, HTR3D TOP2A 4020/4885KDM4E 3157/4885ATM 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback